Propanc Biopharma raises $41K via convertible note with 35% discount conversion

Propanc Biopharma, Inc.

Issued $49,200 convertible promissory note to 1800 Diagonal Lending LLC for $41,000, net proceeds for working capital.
Note bears 15% one-time interest, maturity April 15, 2025, with five scheduled payments totaling $56,580.
Conversion price set at 65% of lowest trading price over 10 prior trading days (35% discount) upon event of default.
Investor is accredited; note issued under Section 4(a)(2) and Regulation D exemption.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.